A
FLGT icon

AlphaQuest’s Fulgent Genetics FLGT Stock Holding History

AlphaQuest’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,521
Closed -$1.04M – 750
2025
Q4 		$1.04M Buy
39,521
+14,496
+58% +$376K 0.06% 428
2025
Q3 		$566K Buy
25,025
+12,231
+96% +$252K 0.04% 713
2025
Q2 		$254K Sell
12,794
-2,786
-18% -$54.3K 0.03% 984
2025
Q1 		$263K Sell
15,580
-20,112
-56% -$343K 0.03% 849
2024
Q4 		$659K Buy
35,692
+27,085
+315% +$529K 0.09% 372
2024
Q3 		$187K Sell
8,607
-9,179
-52% -$205K 0.02% 1097
2024
Q2 		$349K Buy
17,786
+17,718
+26,056% +$370K 0.05% 591
2024
Q1 		$1.48K Buy
+68
New +$1.69K ﹤0.01% 1122

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AlphaQuest's FLGT Position: Q1 2026 in Review

AlphaQuest sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 39,521 shares — an estimated $1.04M sold.

AlphaQuest first reported a position in FLGT in Q1 2024 and held it in 8 quarters. The position peaked at $1.04M in Q4 2025. 158 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • AlphaQuest reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 39,521 Fulgent Genetics shares in Q1 2026, an estimated $1.04M.
  • AlphaQuest first reported a position in Fulgent Genetics in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's Fulgent Genetics position peaked at $1.04M in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.